SCHEMBL9109819

SCHEMBL9109819

[CH2]CC/C=C/CN1CCNCC1

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CXCR4 P61073 2/20 0.31
RAD52 P43351 1/20 0.31
SIGMAR1 Q99720 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9109827 1.00 POLB (0.32) POLBSMN1; SMN2CXCR4RAD52SIGMAR1
SCHEMBL9112135 0.80 LTA4H (0.34)
SCHEMBL9112128 0.80 LTA4H (0.34)
SCHEMBL9112083 0.78 LTA4H (0.33) SIGMAR1
SCHEMBL9112090 0.78 LTA4H (0.33) SIGMAR1
SCHEMBL20244676 0.76 SIGMAR1 (0.38) CXCR4SIGMAR1
SCHEMBL1481329 0.76 POLB (0.35) POLBSMN1; SMN2CXCR4SIGMAR1
SCHEMBL1481327 0.76 POLB (0.35) POLBSMN1; SMN2CXCR4SIGMAR1
SCHEMBL11669571 0.76 CXCR4 (0.54) POLBSMN1; SMN2CXCR4SIGMAR1
SCHEMBL9280593 0.74 POLB (0.34) POLBSMN1; SMN2CXCR4SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0670831-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-09-13 EP disclosed
WO-1995009159-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1995-04-06 WO disclosed